etoposide
UkraineDrugs containing this active substance
-
The drug is used in combination with other chemotherapeutic agents for the treatment of testicular cancer, small cell lung cancer, Hodgkin's disease, non-Hodgkin lymphoma, acute myeloid leukemia, malignant gestational trophoblastic disease, as well as ovarian cancer (non-epithelial in nature and platinum-resistant epithelial cancer).
Form: concentrate for infusion solution
Active substance Dosage etoposide 20 mg/ml ATC: L01CB01
Manufacturer: EBEWE Pharma GmbH & Co. KG (batch release)
-
The drug is used for the treatment of small cell lung cancer, non-seminomatous testicular carcinoma, acute myelomonocytic and myelocytic leukemia, as well as for palliative therapy of non-small cell lung cancer, Hodgkin's disease, non-Hodgkin's lymphoma, and choriocarcinomas.
Form: concentrate for infusion solution
Active substance Dosage etoposide 20 mg/ml ATC: L01CB01
Manufacturer: Venus Remedies Limited
-
The drug is used in combination with other chemotherapeutic agents for the treatment of testicular cancer, small cell lung cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute myeloid leukemia, gestational trophoblastic neoplasia, as well as non-epithelial and platinum-resistant epithelial ovarian cancer.
Form: concentrate for infusion solution
Active substance Dosage etoposide 20 mg/ml ATC: L01CB01
Manufacturer: Farmakemi B.V.